本頁只刊出中文翻譯與中文說明；英文原文請見下方原文連結。
原文連結
論文資訊
- 類型：已發表論文
- 日期：2015
摘要
Jolanta Piszczek and Eric Parlow1 outlined expected benefits of a stepped-wedge cluster trial (SWCT) design, with specific reference to the Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE). STRIVE, however, is not an SWCT, but a phased-rollout trial in which randomisation to immediate or delayed 疫苗接種 groups occurs at the individual level (a randomised clinical trial [RCT]) within trial clusters.2 Whereas the SWCT design is advantageous in certain circumstances, many of the benefits described by Piszczek and Parlow1 would not apply to assessment of Ebola vaccine candidates in Sierra Leone.
※ 此為已發表論文，全文需透過期刊付費取得